Brown et al.34 published a case report of a recurrent glioblastoma patient treated with IL13Rα2 CAR T cells demonstrating significant clinical and radiographic response, although recurrence occurred 7.5 months post-treatment. Here, IL13RA2 is linked to glioblastoma.